Home > Insider Trading > Filing (0000899243-20-017299)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1351288	Gw Pharmaceuticals Plc	GWPH	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1754122	Volker Knappertz	Sovereign House, Vision Park, Histon Cambridge X0 CB24 9BZ	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Disposition	2019-05-15	4,296	$14.63	77,940	No	4	S	Direct
Ordinary Shares	Disposition	2020-06-17	18,000	$10.35	59,940	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2019. Inadvertent late filing.
Represented by American Depositary Shares of the Issuer ("ADSs"). Each ADS represents twelve ordinary shares of the Issuer.
The price reported in Column 4 is a price per ordinary share converted from price per ADS.
Due to an administrative error, the Reporting Person's Form 3 filed with the SEC on October 1, 2018 overstated the Reporting Person's ownership of the Issuer's ordinary shares by 4,440 shares (370 ADSs). These shares have been excluded from Column 5.
Also reflects an adjustment to total holdings to exclude twelve shares incorrectly included in prior reports.
The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2020.